11 |
Characterization and role of collagen gene expressing hepatic cells following partial hepatectomy in mice / マウス肝切除後のコラーゲン遺伝子発現細胞の特徴と役割についてKimura, Yusuke 26 September 2022 (has links)
京都大学 / 新制・課程博士 / 博士(医学) / 甲第24197号 / 医博第4891号 / 新制||医||1060(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 平井 豊博, 教授 万代 昌紀, 教授 伊達 洋至 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DGAM
|
12 |
β - Carotene 15,15-Oxygense 1 (BCO1) Distribution In Parenchymal And Non-Parenchymal Cells In Rat LiverRaghuvanshi, Shiva January 2010 (has links)
No description available.
|
13 |
Ativa??o das c?lulas hep?ticas estreladas e fibrose hep?tica em crian?as portadoras de hepatite autoimune tipo 1: estudo imuno-histoqu?mico de bi?psias hep?ticas pareadas antes do tratamento e ap?s a remiss?o cl?nicaMaia, Jussara Melo de Cerqueira 03 December 2009 (has links)
Made available in DSpace on 2015-03-03T14:02:14Z (GMT). No. of bitstreams: 1
JussaraMCM_Tese.pdf: 1097860 bytes, checksum: 122136921e4dddbf8d0e434cbbbd3653 (MD5)
Previous issue date: 2009-12-03 / The activation of hepatic stellate cells (HSC) is considered the most important event in hepatic fibrogenesis. The precise mechanism of this process is unknown in autoimmune hepatitis (AIH), and more evidence is needed on the evolution of fibrosis. The aim of this study was to assess these aspects in children with type 1 AIH. We analyzed 16 liver biopsy samples from eight patients, paired before treatment and after clinical remission, performed an immunohistochemical study with anti-actin smooth muscle antibody and graded fibrosisand inflammation on a scale of 0:4 (Batts and Ludwig scoring system). We observedthere was no significant reduction in fibrosis scores after 24? 18 months (2.5 ? 0.93 vs. 2.0? 0.53, P = 0.2012). There was an important decrease in inflammation: portal (2.6 ?0.74 vs. 1.3? 0.89, P = 0.0277), periportal/periseptal (3.0 ?0.76 vs. 1.4 ? 1.06, P = 0.0277), and lobular (2.8 ? 1.04 vs. 0.9? 0.99, P =0.0179). Anti-actin smooth muscle antibodies
were expressed in the HSC of the initial biopsies (3491.93 ?2051.48 lm2), showing a significant reduction after remission (377.91 ?439.47 lm2) (P = 0.0117). HSC activation was demonstrated in the AIH of children. The reduction of this activation after clinical remission, which may precede a decrease in fibrosis, opens important perspectives in the follow-up of AIH. / A ativa??o das c?lulas hep?ticas estreladas (CHE) ? considerada o evento mais importante na fibrog?nese hep?tica. Na hepatite autoimune (HAI) este mecanismo ? desconhecido e maiores evid?ncias s?o necess?rias quanto ? evolu??o da fibrose. O
objetivo desse estudo foi avaliar a ativa??o das CHE e a evolu??o da fibrose hep?tica em crian?as portadoras de HAI tipo 1. Foram analisadas 16 bi?psias hep?ticas pareadas de oito pacientes, antes do tratamento e ap?s a remiss?o cl?nica atrav?s de estudo imuno-histoqu?mico com anticorpo anti-??-actina de m?sculo liso e realizada a grada??o da fibrose e da inflama??o empregando-se o sistema de escores de Batts e Ludwig (0-4). N?o houve significante redu??o nos escores de fibrose ap?s intervalo de tempo de 24? 18 meses entre as bi?psias (2,5 ? 0,93 vs.
2,0? 0,53, P = 0,2012). Observou-se redu??o significante na inflama??o: portal (2,6?0,74 vs. 1,3? 0,89, P = 0,0277), periportal/perisseptal (3,0 ?0,76 vs. 1,4 ? 1,06, P =0,0277) e lobular (2,8 ? 1,04 vs. 0,9? 0,99, P =0,0179). A -actina de m?sculo liso nas CHE foi expressa em bi?psias hep?ticas iniciais (3491,93 ?2051,48 ?m2) e mostrou significante redu??o ap?s a remiss?o cl?nica (377,91 ?439,47 ?m2) (P = 0,0117). A ativa??o de CHE foi demonstrada em crian?as portadoras de HAI tipo 1.
A redu??o de sua ativa??o ap?s remiss?o cl?nica, a qual pode preceder a redu??o da fibrose, abre importantes perspectivas no follow-up da HAI
|
14 |
Participação das conexinas 43 e 32 no desenvolvimento da fibrose hepática: estudo em camundongos geneticamente modificados / Role of connexins 43 and 32 on the development of hepatic fibrosis: a study in genetically modified miceCogliati, Bruno 23 April 2010 (has links)
A fibrose hepática resulta da cronicidade da injúria celular, ocasionando acúmulo dos componentes da matriz extracelular (MEC) pela ativação, principalmente, de células estreladas e fibroblastos portais em miofibroblastos. Estas células se conectam através de junções comunicantes do tipo gap, formadas por proteínas denominadas conexinas (Cx). As junções gap são responsáveis pelo fluxo de moléculas e íons entre as células, desempenhando importante função no controle da homeostasia tecidual. Diversos tipos de conexinas foram descritas nas células hepáticas. Os hepatócitos expressam Cx32 e Cx26, enquanto as demais células não-parenquimatosas expressam Cx43. Alguns estudos analisaram a expressão das conexinas e das junções gap em processos de reparação e fibrogênese em diferentes tecidos, no entanto, poucos avaliaram seu papel na fibrogênese hepática. Sendo assim, o objetivo deste estudo foi avaliar os aspectos morfológicos, histopatológicos e moleculares da fibrose hepática, induzida por tetracloreto de carbono (CCl4), em animais deficientes para as conexinas 43 (Cx43+/-) ou 32 (Cx32-/-). Foram analisados dados biométricos, histopatológicos, ultra-estruturais, imuno-histoquímicos e bioquímicos, além da expressão gênica e protéica das conexinas. Os aspectos moleculares da fibrose hepática foram analisados pela expressão de genes relacionados com a deposição e degradação da matriz extracelular por PCR em tempo real. As análises macroscópicas e de varredura demonstraram um processo de micronodulação da superfície hepática mais acentuado nos camundongos Cx43+/- fibróticos em relação aos animais wild-type (Cx43+/+) fibróticos. Adicionalmente, estes animais apresentaram maior proporção volumétrica de colágeno no tecido hepático; redução na atividade necroinflamatória tecidual; redução nas concentrações séricas de AST e ALT; redução na proliferação celular dos hepatócitos e redução na expressão dos genes: colágeno tipo I, TGFβ-1, MMP-2, MMP-13 e TIMP-1. Por sua vez, os camundongos Cx32-/- fibróticos apresentaram aumento na deposição de colágeno no parênquima hepático; aumento na atividade necroinflamatória tecidual e aumento nos níveis séricos das enzimas hepáticas AST, ALT e fosfatase alcalina em comparação aos animais wild-type (Cx32+/+) fibróticos. Também foram observadas redução na proliferação hepatocelular e maior quantidade de corpúsculos apoptóticos no tecido hepático. Baseando-se em todos os resultados obtidos, observou-se que ambos os modelos animais apresentaram aumento da fibrose hepática, aparentemente ocasionada por diferentes modos de ação. Os animais deficientes em Cx43 apresentaram menor capacidade de degradação do colágeno, ocasionando seu acúmulo no tecido hepático. Por outro lado, os animais deficientes em Cx32 apresentaram maior deposição de colágeno em resposta à injúria hepatocelular mais acentuada, aliada ao desequilíbrio entre as taxas de proliferação celular e apoptose. Em conclusão, os resultados obtidos neste trabalho demonstraram a importante participação das conexinas no controle da fibrogênese hepática, e que podem representar potenciais alvos terapêuticos para o tratamento das doenças hepáticas crônicas em humanos e animais. / Hepatic fibrosis results from chronic cell injury, leading to accumulation of components of extracellular matrix (ECM) through activation mainly of hepatic stellate cells and portal fibroblasts into myofibroblasts. These cells communicate through intercellular gap junctions composed of proteins known as connexins (Cx). Gap junctions are responsible for the exchange of molecules and ions among cells, playing an important role in the control of tissue homeostasis. Several subtypes of connexins were described among hepatic cells. Hepatocytes express Cx32 and Cx26, while the other non-parenchymal cells express Cx43. Some studies analyzed the expression of connexins and gap junctions on processes of healing and fibrogenesis in different tissues; however, few studies evaluated its role on hepatic fibrogenesis. Thus, the objective of this study was to evaluate morphological, histopathological and molecular aspects of hepatic fibrosis induced by carbon tetrachloride (CCl4) in animals with connexin 43 (Cx43+/-) or 32 (Cx32-/-) deficiency. We analyzed biometric, histopathological, ultrastructural, immunohistochemical and biochemical data, besides gene and protein expression of connexins. Molecular aspects of hepatic fibrosis were analyzed with the expression of genes related to deposition and degradation of extracellular matrix by real time PCR. Macroscopic and Scanning Electron Microscopy analyses showed a process of micronodulation of hepatic surface more accentuated on Cx43+/- fibrotic mice when compared to fibrotic wild-type (Cx43+/+) animals. Additionally, these animals presented a higher collagen volumetric proportion on hepatic tissue; reduction of tissue necroinflammatory activity; reduction of serum AST and ALT; reduction of hepatocytes proliferation and reduction of expression type I collagen, TGFβ-1, MMP-2, MMP-13 and TIMP-1 genes. Fibrotic Cx32-/- mice presented an increase of collagen deposition in hepatic parenchyma; increase of tissue necro-inflammatory activity and increase of liver enzymes AST, ALT and alkaline phosphatase when compared to fibrotic wild-type (Cx32+/+) animals. Reduction of hepatocellular proliferation and a higher amount of apoptotic bodies on hepatic tissue were also observed. Based on the results obtained, we observed that both animal models showed an increase of hepatic fibrosis, apparently caused by different modes of action. Cx43 deficient animals showed a reduced capacity to degrade collagen, causing its accumulation in the hepatic tissue. Cx32 deficient animals showed an increased collagen deposition in response to accentuated hepatocellular injury, together to an unbalance between rates of cellular proliferation and apoptosis. In conclusion, results obtained on this study demonstrate an important role of connexins on the control of hepatic fibrogenesis, which could represent potential therapeutical targets for the treatment of chronic liver diseases in humans and animals.
|
15 |
Participação das conexinas 43 e 32 no desenvolvimento da fibrose hepática: estudo em camundongos geneticamente modificados / Role of connexins 43 and 32 on the development of hepatic fibrosis: a study in genetically modified miceBruno Cogliati 23 April 2010 (has links)
A fibrose hepática resulta da cronicidade da injúria celular, ocasionando acúmulo dos componentes da matriz extracelular (MEC) pela ativação, principalmente, de células estreladas e fibroblastos portais em miofibroblastos. Estas células se conectam através de junções comunicantes do tipo gap, formadas por proteínas denominadas conexinas (Cx). As junções gap são responsáveis pelo fluxo de moléculas e íons entre as células, desempenhando importante função no controle da homeostasia tecidual. Diversos tipos de conexinas foram descritas nas células hepáticas. Os hepatócitos expressam Cx32 e Cx26, enquanto as demais células não-parenquimatosas expressam Cx43. Alguns estudos analisaram a expressão das conexinas e das junções gap em processos de reparação e fibrogênese em diferentes tecidos, no entanto, poucos avaliaram seu papel na fibrogênese hepática. Sendo assim, o objetivo deste estudo foi avaliar os aspectos morfológicos, histopatológicos e moleculares da fibrose hepática, induzida por tetracloreto de carbono (CCl4), em animais deficientes para as conexinas 43 (Cx43+/-) ou 32 (Cx32-/-). Foram analisados dados biométricos, histopatológicos, ultra-estruturais, imuno-histoquímicos e bioquímicos, além da expressão gênica e protéica das conexinas. Os aspectos moleculares da fibrose hepática foram analisados pela expressão de genes relacionados com a deposição e degradação da matriz extracelular por PCR em tempo real. As análises macroscópicas e de varredura demonstraram um processo de micronodulação da superfície hepática mais acentuado nos camundongos Cx43+/- fibróticos em relação aos animais wild-type (Cx43+/+) fibróticos. Adicionalmente, estes animais apresentaram maior proporção volumétrica de colágeno no tecido hepático; redução na atividade necroinflamatória tecidual; redução nas concentrações séricas de AST e ALT; redução na proliferação celular dos hepatócitos e redução na expressão dos genes: colágeno tipo I, TGFβ-1, MMP-2, MMP-13 e TIMP-1. Por sua vez, os camundongos Cx32-/- fibróticos apresentaram aumento na deposição de colágeno no parênquima hepático; aumento na atividade necroinflamatória tecidual e aumento nos níveis séricos das enzimas hepáticas AST, ALT e fosfatase alcalina em comparação aos animais wild-type (Cx32+/+) fibróticos. Também foram observadas redução na proliferação hepatocelular e maior quantidade de corpúsculos apoptóticos no tecido hepático. Baseando-se em todos os resultados obtidos, observou-se que ambos os modelos animais apresentaram aumento da fibrose hepática, aparentemente ocasionada por diferentes modos de ação. Os animais deficientes em Cx43 apresentaram menor capacidade de degradação do colágeno, ocasionando seu acúmulo no tecido hepático. Por outro lado, os animais deficientes em Cx32 apresentaram maior deposição de colágeno em resposta à injúria hepatocelular mais acentuada, aliada ao desequilíbrio entre as taxas de proliferação celular e apoptose. Em conclusão, os resultados obtidos neste trabalho demonstraram a importante participação das conexinas no controle da fibrogênese hepática, e que podem representar potenciais alvos terapêuticos para o tratamento das doenças hepáticas crônicas em humanos e animais. / Hepatic fibrosis results from chronic cell injury, leading to accumulation of components of extracellular matrix (ECM) through activation mainly of hepatic stellate cells and portal fibroblasts into myofibroblasts. These cells communicate through intercellular gap junctions composed of proteins known as connexins (Cx). Gap junctions are responsible for the exchange of molecules and ions among cells, playing an important role in the control of tissue homeostasis. Several subtypes of connexins were described among hepatic cells. Hepatocytes express Cx32 and Cx26, while the other non-parenchymal cells express Cx43. Some studies analyzed the expression of connexins and gap junctions on processes of healing and fibrogenesis in different tissues; however, few studies evaluated its role on hepatic fibrogenesis. Thus, the objective of this study was to evaluate morphological, histopathological and molecular aspects of hepatic fibrosis induced by carbon tetrachloride (CCl4) in animals with connexin 43 (Cx43+/-) or 32 (Cx32-/-) deficiency. We analyzed biometric, histopathological, ultrastructural, immunohistochemical and biochemical data, besides gene and protein expression of connexins. Molecular aspects of hepatic fibrosis were analyzed with the expression of genes related to deposition and degradation of extracellular matrix by real time PCR. Macroscopic and Scanning Electron Microscopy analyses showed a process of micronodulation of hepatic surface more accentuated on Cx43+/- fibrotic mice when compared to fibrotic wild-type (Cx43+/+) animals. Additionally, these animals presented a higher collagen volumetric proportion on hepatic tissue; reduction of tissue necroinflammatory activity; reduction of serum AST and ALT; reduction of hepatocytes proliferation and reduction of expression type I collagen, TGFβ-1, MMP-2, MMP-13 and TIMP-1 genes. Fibrotic Cx32-/- mice presented an increase of collagen deposition in hepatic parenchyma; increase of tissue necro-inflammatory activity and increase of liver enzymes AST, ALT and alkaline phosphatase when compared to fibrotic wild-type (Cx32+/+) animals. Reduction of hepatocellular proliferation and a higher amount of apoptotic bodies on hepatic tissue were also observed. Based on the results obtained, we observed that both animal models showed an increase of hepatic fibrosis, apparently caused by different modes of action. Cx43 deficient animals showed a reduced capacity to degrade collagen, causing its accumulation in the hepatic tissue. Cx32 deficient animals showed an increased collagen deposition in response to accentuated hepatocellular injury, together to an unbalance between rates of cellular proliferation and apoptosis. In conclusion, results obtained on this study demonstrate an important role of connexins on the control of hepatic fibrogenesis, which could represent potential therapeutical targets for the treatment of chronic liver diseases in humans and animals.
|
16 |
A importância da interação entre estresse oxidativo, biogênese de mitocôndrias e mitofagia na resposta de células estreladas hepáticas ao resveratrolMartins, Leo Anderson Meira January 2014 (has links)
A fibrose hepática é uma patologia que acompanha outras doenças crônicas do fígado como a cirrose e o hepatocarcinoma. As células estreladas hepáticas (HSC, do inglês hepatic stellate cells) compõem uma população celular heterogênea que se caracteriza por transitar entre dois fenótipos. As células com fenótipo quiescente possuem a capacidade de armazenar vitamina A em gotas lipídicas. Os insultos ao fígado desencadeiam uma resposta inflamatória que gera estímulos parácrinos e autócrinos mediados por citocinas e espécies reativas. Neste contexto, as HSC assumem um fenótipo ativado fibrogênico e tornam-se responsáveis pela cicatrização hepática. Danos crônicos ao fígado levam a uma deposição de matriz extracelular exagerada que configura o estado patológico da fibrose. O resveratrol (RSV – 3,4’,5-tri-hidroxi-trans-estilbeno) é uma fitoalexina produzida por algumas espécies de plantas. Inúmeros efeitos benéficos à saúde são atribuídos ao RSV por causa do seu potencial antioxidante, antiinflamatório e pró-apoptótico. Estudos anteriores mostraram que tratamento da GRX, uma linhagem murina de HSC ativadas, com concentrações de RSV próximas as biodisponíveis (0,1 a 1 μM) resultou em parada do ciclo na fase S com consequente inibição de proliferação celular, um efeito associado à citotoxicidade e que pode favorecer a resolução da fibrose hepática. Neste estudo, por técnicas espectrofotométricas, foi demonstrado que tratamento da GRX por 24 horas com concentrações entre 0,1 a 50 μM de RSV promoveu um efeito pró-oxidante que causa uma citotoxicidade dependente da dose, bastante aumentada no grupo tratado com a concentração mais alta. Os efeitos citotóxicos atenuados encontrados nas células tratadas por 120 horas sugerem que a GRX pode se tornar resistente a estes efeitos. O potencial pró-oxidante do RSV foi o ponto de partida para investigar a possibilidade de que esta fitoalexina provocasse uma alteração no metabolismo mitocondrial da GRX. Para isso, os efeitos do RSV (1 a 50 μM) na função mitocondrial, na indução de morte mediada por estas organelas e na autofagia/mitofagia foram investigados por técnicas de espectrofotometria, de imunocitoquímica, de citometria de fluxo, de microscopia confocal e de microscopia eletrônica de transmissão em GRX tratadas por 24 e 120 horas. Foi demonstrado que todas as concentrações de RSV promovem apoptose por meio da ativação de caspases, alteram a dinâmica/função mitocondrial e induzem o aumento de autofagia/mitofagia na GRX. No entanto, o RSV provocou biogênese de mitocôndrias nos grupos tratados com 1 e 10 μM, enquanto que o tratamento com 50 μM causou dano celular evidente na GRX, sem induzir biogênese de mitocôndrias. Desta forma, é possível que a citotoxicidade “dose-dependente” do RSV, que causa a morte celular e dano oxidativo em 24 horas de tratamento, esteja relacionada com o desequilíbrio entre a indução concomitante de apoptose mediada por dano mitocondrial, autofagia/mitofagia e biogênese de mitocôndrias. Por fim, foi investigada a liberação de TNF-α, Interleucina-6 e Interleucina-10 pela GRX tratada por 24 e 120 horas com RSV (0,1 a 50 μM), considerando o papel antiinflamatório do RSV e o papel das HSC ativadas na sinalização autócrina que contribui para a modulação fenotípica destas células. Foi demonstrado que o tratamento da GRX com RSV por 24 e 120 horas induziu a redução da liberação de Interleucina-6; enquanto que a liberação de TNF-α e Interleucina-10 foi aumentada. Estes resultados confirmam um efeito antiinflamatório do RSV que deve contribuir na prevenção da ativação ou da perpetuação do estado ativado das HSC por meio de sinalização autócrina. Ainda que a concentração do RSV seja importante para efetivamente induzir a morte das HSC ativadas, o tratamento com esta fitoalexina pode ser promissor para a resolução da fibrose hepática por diminuir a população de células ativadas e, possivelmente, prevenir a perpetuação do estado fenotípico ativado. Estudos avaliando indicadores de quiescência em células tratadas são ainda necessários para desvendar completamente os efeitos do RSV quanto às possibilidades de inibição da perpetuação ou reversão fenotípica das HSC ativadas. / Liver fibrosis is a disease that accompanies other hepatic chronic diseases such as cirrhosis and hepatocellular carcinoma. Hepatic stellate cells (HSC) are a heterogeneous cell population characterized by transiting between two phenotypes. Cells with a quiescent phenotype are able to store vitamin A into lipid droplets. Damage to the liver trigger an inflammatory response that generates paracrine and autocrine stimulation mediated by cytokines and reactive species. In this context, HSC assume an activated and fibrogenic phenotype responsive for hepatic wound-healing. Chronic insults to the liver lead to an excessive deposition of extracellular matrix that configures the pathological state of fibrosis. Resveratrol (RSV – 3,4’,5-tri-hidroxi-trans-stilbeno) is a phytoalexin produced by some species of plants. Several beneficial effects are attributed to this molecule due to its antioxidant, antiproliferative and pro-apoptotic potential. Previous studies showed that treatment with bioavailable concentrations of RSV (0.1 to 1 μM) promoted an arrest cycle at the S phase in GRX, a murine activated HSC model, leading to cell proliferation inhibition, a cytotoxic effect that contributes to the liver fibrosis resolution. In this study, it was shown by spectrophotometric techniques that GRX treatment for 24 hours at concentrations between 0.1 to 50 μM of RSV promoted a fairly clear pro-oxidant effect that causes a dose-dependent cytotoxicity that was higher in the group treated with 50 μM. The attenuated cytotoxicity found after 120 hours of GRX treatment suggest that these cells became resistant to this effect. The pro-oxidant potential of RSV was the starting point for investigating the possibility that this phytoalexin would cause a change in the GRX mitochondrial metabolism. Thus, the effects of RSV (1 to 50 μM) on altering the mitochondrial function, on inducing mitochondrial-mediated cell death, and autophagy/mitofagia were investigated in GRX treated for 24 and 120 hours by spectrophotometric techniques, immunocytochemistry, flow cytometry, confocal microscopy, and transmission electron microscopy. All the RSV concentrations promote cell apoptosis through caspases activation, alter the mitochondrial dynamics and function, and induce an increase of autophagy/mitofagia. Curiously, only 1 and 10 μM of RSV induced mitochondrial biogenesis in GRX, while the highest concentration caused an evident cell damage without inducing mitochondrial biogenesis. Thus, it is possible that the "dose-dependent" cytotoxicity of RSV, which causes cell death and oxidative damage in 24 hours of treatment, is related to an imbalance between the concomitant induction of mitochondrial-mediated apoptosis, autophagy/mitofagia, and mitochondrial biogenesis. Finally, it was investigated the release of TNF-α, Interleukin-6 and Interleukin-10 by GRX treated for 24 and 120 hours with RSV (0.1 to 50 μM), considering the anti-inflammatory role of RSV and the autocrine signalling role of HSC that contributes to the perpetuation of its activated phenotype. It was demonstrated that GRX treatment with RSV for 24 and 120 hours reduced the release of Interleukin-6 in the culture medium; whereas the release of TNF-α and Interleukin-10 was increased. These results confirm the anti-inflammatory properties of RSV and may contribute to the prevention of HSC activation through autocrine signalling. Although RSV concentration is important to effectively induce activated HSC death, cells treatment with this phytoalexin may be promising for liver fibrosis resolution through decreasing the population of activated cells or through preventing the perpetuation of activated state of HSC. Future studies evaluating the quiescence indicators of GRX under RSV treatment are still needed to fully unravel the effects of this phytoalexin on inhibiting the perpetuation of activated HSC or reversing its activated phenotype.
|
17 |
IL - 17 et réponse inflammatoire systémique : focus sur le foie et le muscle / IL-17 and systemic inflammatory response : focus on the liver and the muscleBeringer, Audrey 13 December 2018 (has links)
L’interleukine (IL)-17 et le TNFa sont deux cytokines pro-inflammatoires jouant un rôle important dans diverses maladies inflammatoires systémiques et auto-immunes affectant différents organes et tissus comme le foie et les muscles. Cependant, les rôles de l’IL-17 et du TNFa restent encore mal compris dans les muscles et le foie, qui est impliqué dans la réponse en phase aiguë. En utilisant des cultures de myoblastes, d’hépatocytes et de cellules stellaires hépatiques humaines, nous avons trouvé que l’IL-17 et le TNFa augmentent en synergie la sécrétion de la cytokine pro-inflammatoire IL-6 et de plusieurs chimiokines. Dans les myoblastes, l’IL-17 et le TNFa induisent un stress oxydatif et une dérégulation de calcium montrant ainsi que les processus pathologiques immuns et non-immuns interagissent. Dans les hépatocytes, en augmentant en synergie les niveaux de la CRP et des transaminases, l’IL-17 et le TNFa participent à l’inflammation systémique et aux dommages cellulaires. Etant donné que des infiltrats de cellules immunitaires sont retrouvés lors d’atteintes inflammatoires, les interactions cellulaires contribuent certainement à la chronicité de l’inflammation. Des cellules mononuclées du sang périphérique activées ou non ont ainsi été placées en co-cultures avec les myoblastes, les hépatocytes et les cellules stellaires. Par comparaison aux monocultures, les productions de l’IL-6 et de la chimiokine IL-8 étaient augmentées dans les co-cultures. L’IL-17 et le TNFa contribuaient partiellement à ces effets. Les effets systémiques de l’IL-17 et du TNFa en font donc des cibles thérapeutiques attrayantes pour le traitement des nombreuses maladies inflammatoires systémiques / Interleukin-17A (IL-17) and tumor necrosis factor-a (TNFa) are two pro-inflammatory cytokines playing an important role in various systemic inflammatory and autoimmune disorders affecting different organs and tissues including the liver and the muscles. However, the roles of IL-17 and TNFa are not fully understood in the muscles and also in liver, which is crucial in the acute phase response. By using cultures of human myoblasts, primary human hepatocytes, human HepaRG cells and LX-2 hepatic stellate cells, we found that IL-17 and TNFa increase in synergy the production of the pro-inflammatory cytokine IL-6 and chemokines (IL-8, CCL20, MCP-1). In myoblasts, the IL-17 and TNFa stimulation induces endoplasmic reticulum stress and calcium dysregulation showing that immune and non-immune pathogenic mechanisms interplay. In hepatocytes, IL-17 and TNFa mediate systemic inflammation and cell damage by increasing in synergy the CRP acute-phase protein and transaminase levels through the induction of IL-6. Since active liver and muscle disorders are characterized by inflammatory infiltrates of immune cells, the cell interactions play certainly an important role in the chronicity of the inflammation. Peripheral blood mononuclear cells activated or not were therefore co-cultured with myoblasts, hepatocytes and/or hepatic stellate cells to assess the inflammatory role of the cell-cell interactions. Co-cultures enhance the production of IL-6 and IL-8 compared to monocultures. IL-17 and TNFa contribute partially to these inductions. The systemic effects of IL-17 and/or TNFa make them attractive therapeutic targets for the treatment of various systemic inflammatory disorders
|
18 |
Vliv složek extracelulární matrix na buňky kultivované in vitro / The Influence of Extracellular Matrix Components to Cells Cultured In VitroPeterová, Eva January 2017 (has links)
Myofibroblast expansion is a critical event in the pathogenesis of liver fibrosis. The activation of hepatic stellate cells (HSC) to myofibroblast (MFB) results in the enhanced production of extracellular matrix (ECM). We have studied the effect of fibroblast growth factor 1 (FGF-1) on liver MFB. In the second part we investigated effect of transforming growth factor β1 (TGF-β1) and FGF-1 on cell line HSC-T6. Cells were cultured on plastic dishes and in 3D collagen gel mimicking fibrotic tissue. MFB were isolated by repeated passaging of nonparenchymal liver cell fraction. The transfer of MFB from plastic dishes to collagen gel resulted in the change in their shape and phenotype. The expression of cytokine TGF-β1 and of MFB markers, α-smooth muscle actin (α-SMA) and cellular fibronectin (EDA-FN) on protein level was significantly decreased in collagen gel. The experiments with SB 431542, the inhibitor of TGF-β receptor type I, showed that EDA-FN and α-SMA are differently regulated. EDA-FN expression is dependent on TGF-β1, while the expression of α-SMA is primarily determined by the environment and modified by TGF-β1. EDA-FN is more sensitive to the U0126, the inhibitor of protein kinases MEK 1 and 2. Collagen gel does not change the expression of metalloproteinase MMP-2 but activates the proenzyme....
|
19 |
A importância da interação entre estresse oxidativo, biogênese de mitocôndrias e mitofagia na resposta de células estreladas hepáticas ao resveratrolMartins, Leo Anderson Meira January 2014 (has links)
A fibrose hepática é uma patologia que acompanha outras doenças crônicas do fígado como a cirrose e o hepatocarcinoma. As células estreladas hepáticas (HSC, do inglês hepatic stellate cells) compõem uma população celular heterogênea que se caracteriza por transitar entre dois fenótipos. As células com fenótipo quiescente possuem a capacidade de armazenar vitamina A em gotas lipídicas. Os insultos ao fígado desencadeiam uma resposta inflamatória que gera estímulos parácrinos e autócrinos mediados por citocinas e espécies reativas. Neste contexto, as HSC assumem um fenótipo ativado fibrogênico e tornam-se responsáveis pela cicatrização hepática. Danos crônicos ao fígado levam a uma deposição de matriz extracelular exagerada que configura o estado patológico da fibrose. O resveratrol (RSV – 3,4’,5-tri-hidroxi-trans-estilbeno) é uma fitoalexina produzida por algumas espécies de plantas. Inúmeros efeitos benéficos à saúde são atribuídos ao RSV por causa do seu potencial antioxidante, antiinflamatório e pró-apoptótico. Estudos anteriores mostraram que tratamento da GRX, uma linhagem murina de HSC ativadas, com concentrações de RSV próximas as biodisponíveis (0,1 a 1 μM) resultou em parada do ciclo na fase S com consequente inibição de proliferação celular, um efeito associado à citotoxicidade e que pode favorecer a resolução da fibrose hepática. Neste estudo, por técnicas espectrofotométricas, foi demonstrado que tratamento da GRX por 24 horas com concentrações entre 0,1 a 50 μM de RSV promoveu um efeito pró-oxidante que causa uma citotoxicidade dependente da dose, bastante aumentada no grupo tratado com a concentração mais alta. Os efeitos citotóxicos atenuados encontrados nas células tratadas por 120 horas sugerem que a GRX pode se tornar resistente a estes efeitos. O potencial pró-oxidante do RSV foi o ponto de partida para investigar a possibilidade de que esta fitoalexina provocasse uma alteração no metabolismo mitocondrial da GRX. Para isso, os efeitos do RSV (1 a 50 μM) na função mitocondrial, na indução de morte mediada por estas organelas e na autofagia/mitofagia foram investigados por técnicas de espectrofotometria, de imunocitoquímica, de citometria de fluxo, de microscopia confocal e de microscopia eletrônica de transmissão em GRX tratadas por 24 e 120 horas. Foi demonstrado que todas as concentrações de RSV promovem apoptose por meio da ativação de caspases, alteram a dinâmica/função mitocondrial e induzem o aumento de autofagia/mitofagia na GRX. No entanto, o RSV provocou biogênese de mitocôndrias nos grupos tratados com 1 e 10 μM, enquanto que o tratamento com 50 μM causou dano celular evidente na GRX, sem induzir biogênese de mitocôndrias. Desta forma, é possível que a citotoxicidade “dose-dependente” do RSV, que causa a morte celular e dano oxidativo em 24 horas de tratamento, esteja relacionada com o desequilíbrio entre a indução concomitante de apoptose mediada por dano mitocondrial, autofagia/mitofagia e biogênese de mitocôndrias. Por fim, foi investigada a liberação de TNF-α, Interleucina-6 e Interleucina-10 pela GRX tratada por 24 e 120 horas com RSV (0,1 a 50 μM), considerando o papel antiinflamatório do RSV e o papel das HSC ativadas na sinalização autócrina que contribui para a modulação fenotípica destas células. Foi demonstrado que o tratamento da GRX com RSV por 24 e 120 horas induziu a redução da liberação de Interleucina-6; enquanto que a liberação de TNF-α e Interleucina-10 foi aumentada. Estes resultados confirmam um efeito antiinflamatório do RSV que deve contribuir na prevenção da ativação ou da perpetuação do estado ativado das HSC por meio de sinalização autócrina. Ainda que a concentração do RSV seja importante para efetivamente induzir a morte das HSC ativadas, o tratamento com esta fitoalexina pode ser promissor para a resolução da fibrose hepática por diminuir a população de células ativadas e, possivelmente, prevenir a perpetuação do estado fenotípico ativado. Estudos avaliando indicadores de quiescência em células tratadas são ainda necessários para desvendar completamente os efeitos do RSV quanto às possibilidades de inibição da perpetuação ou reversão fenotípica das HSC ativadas. / Liver fibrosis is a disease that accompanies other hepatic chronic diseases such as cirrhosis and hepatocellular carcinoma. Hepatic stellate cells (HSC) are a heterogeneous cell population characterized by transiting between two phenotypes. Cells with a quiescent phenotype are able to store vitamin A into lipid droplets. Damage to the liver trigger an inflammatory response that generates paracrine and autocrine stimulation mediated by cytokines and reactive species. In this context, HSC assume an activated and fibrogenic phenotype responsive for hepatic wound-healing. Chronic insults to the liver lead to an excessive deposition of extracellular matrix that configures the pathological state of fibrosis. Resveratrol (RSV – 3,4’,5-tri-hidroxi-trans-stilbeno) is a phytoalexin produced by some species of plants. Several beneficial effects are attributed to this molecule due to its antioxidant, antiproliferative and pro-apoptotic potential. Previous studies showed that treatment with bioavailable concentrations of RSV (0.1 to 1 μM) promoted an arrest cycle at the S phase in GRX, a murine activated HSC model, leading to cell proliferation inhibition, a cytotoxic effect that contributes to the liver fibrosis resolution. In this study, it was shown by spectrophotometric techniques that GRX treatment for 24 hours at concentrations between 0.1 to 50 μM of RSV promoted a fairly clear pro-oxidant effect that causes a dose-dependent cytotoxicity that was higher in the group treated with 50 μM. The attenuated cytotoxicity found after 120 hours of GRX treatment suggest that these cells became resistant to this effect. The pro-oxidant potential of RSV was the starting point for investigating the possibility that this phytoalexin would cause a change in the GRX mitochondrial metabolism. Thus, the effects of RSV (1 to 50 μM) on altering the mitochondrial function, on inducing mitochondrial-mediated cell death, and autophagy/mitofagia were investigated in GRX treated for 24 and 120 hours by spectrophotometric techniques, immunocytochemistry, flow cytometry, confocal microscopy, and transmission electron microscopy. All the RSV concentrations promote cell apoptosis through caspases activation, alter the mitochondrial dynamics and function, and induce an increase of autophagy/mitofagia. Curiously, only 1 and 10 μM of RSV induced mitochondrial biogenesis in GRX, while the highest concentration caused an evident cell damage without inducing mitochondrial biogenesis. Thus, it is possible that the "dose-dependent" cytotoxicity of RSV, which causes cell death and oxidative damage in 24 hours of treatment, is related to an imbalance between the concomitant induction of mitochondrial-mediated apoptosis, autophagy/mitofagia, and mitochondrial biogenesis. Finally, it was investigated the release of TNF-α, Interleukin-6 and Interleukin-10 by GRX treated for 24 and 120 hours with RSV (0.1 to 50 μM), considering the anti-inflammatory role of RSV and the autocrine signalling role of HSC that contributes to the perpetuation of its activated phenotype. It was demonstrated that GRX treatment with RSV for 24 and 120 hours reduced the release of Interleukin-6 in the culture medium; whereas the release of TNF-α and Interleukin-10 was increased. These results confirm the anti-inflammatory properties of RSV and may contribute to the prevention of HSC activation through autocrine signalling. Although RSV concentration is important to effectively induce activated HSC death, cells treatment with this phytoalexin may be promising for liver fibrosis resolution through decreasing the population of activated cells or through preventing the perpetuation of activated state of HSC. Future studies evaluating the quiescence indicators of GRX under RSV treatment are still needed to fully unravel the effects of this phytoalexin on inhibiting the perpetuation of activated HSC or reversing its activated phenotype.
|
20 |
Caractérisation morphologique, biochimique et physiologique des protéines de jonction lacunaire, les connexines 46 et 50, dans les cellules folliculo-stellaires TtT/GF de l’hypophyse antérieureGarcia, Christopher 04 1900 (has links)
Les cellules folliculo-stéllaires (FS) de l'hypophyse antérieure possèdent une forme étoilée et étendent de longues projections cytoplasmiques qui forment des pseudo-follicules entourant les cellules endocrines. Les cellules FS sont connectées entre elles par des jonctions lacunaires (des fois aussi connu sous le nom de jonction communicante) formant ainsi un réseau tridimensionnel continu. Un des rôles principaux des cellules FS est le maintien du microenvironnement de l'hypophyse antérieure, une activité qui est en partie réalisée par la sécrétion de divers facteurs de croissance et de cytokines. Ces messagers chimiques, y compris le bFGF, le VEGF, l’IL-6 et l’IL-1 contrôlent de nombreux processus cellulaires tels que l’expression des gènes d’hormones. Notre intérêt est de déterminer si la communication entre les cellules FS contribue à leur activité régulatrice. Dans notre étude, nous avons utilisé la lignée cellulaire TtT/GF qui partage de nombreuses caractéristiques morphologiques, physiologiques et biochimiques avec les cellules FS.
Les jonctions lacunaires/communicantes sont formées par l’association de deux connexons de cellules adjacentes qui unissent le cytoplasme des cellules connectées et permet la diffusion de petites molécules. Chaque connexon est formé par l’oligomérisation de six protéines connexine (Cx) de la famille α, β ou γ. Les connexons, intégrés dans la membrane d’une vésicule du cytoplasme, se migrent vers la membrane cellulaire où ils s’incorporent dans la couche bilipidique.
L’expression de la Cx43 (α) par les cellules FS est régulée en réponse à des facteurs de croissance et des cytokines. Des changements dans le microenvironnement de l'hypophyse antérieure causés par des molécules de signalisation sont susceptibles de modifier la Cx43, en particulier l’état de phosphorylation de la protéine. Ces modifications de la Cx43 peuvent ensuite déclencher des changements du comportement de jonctions lacunaires/communicantes formées par la Cx43, comme leur perméabilité et le renouvellement de la protéine Cx43.
Les tissus expriment généralement plus d’un type de connexine. Jusqu’aujourd’hui, la Cx43 est la seule connexine à avoir été identifiée dans les cellules FS. Le cristallin exprime les connexines α: Cx43, Cx46 et Cx50. Leur expression est modulée par des facteurs de croissance. Notre hypothèse de travail a été de vérifier si la Cx46 et la Cx50 étaient exprimées par les cellules FS et si celles-ci contribuaient au rôle modulateur des cellules FS hypophysaires.
Dans cette étude, nous avons identifié et caractérisé la Cx46 et la Cx50 dans la lignée cellulaire TtT/GF. Nous avons identifié les produits de transcription de Cx46 et de Cx50 par la technique d’analyse northern blot (PCR). Par la suite, les protéines Cx46 et Cx50 ont été identifiées en utilisant des anticorps dans des analyses western blot. Par microscopie confocale, nous avons déterminé la co-localisation de la Cx46 avec certaines marqueurs d’organites : réseau trans-Golgien, endosomes précoces et lysosomes. La Cx50 co-localise avec des marqueurs du réticulum endoplasmique, du réseau cis-Golgien et des endosomes précoces. Un protocole d’isolation des membranes résistantes aux détergents non-ionique a révélé que la Cx46 et la Cx50 n’étaient pas associées à des radeaux lipidiques ni aux cavéoles. Cependant, la microscopie confocale a montré une co-localisation cytoplasmique de la Cx50 et de la flotilline-1.
Nous avons poursuivi l’étude sur la localisation de la Cx46 dans le noyau en utilisant une technique d’isolation des fractions enrichies en noyau. Nous avons établi que plusieurs isoformes de la Cx46 sont exclusivement associées au noyau. De plus, avec la microscopie confocale nous avons démontrée une co-localisation de la Cx46 avec un marqueur du nucléole/corps de Cajal.
Nous avons démontré un effet du bFGF sur l'expression temporelle de la Cx46 et de la Cx50. L’expression de la Cx46 diminue au cours de longues expositions au bFGF tandis que les niveaux de Cx50 augmentent de façon transitoire au cours du traitement. Dans une autre étude nous avons démontré des changements importants dans les niveaux de la Cx46 et de la Cx50 dans l’hypophyse antérieure des visons durant le cycle de reproduction annuel.
Notre étude démontre que les cellules FS expriment la Cx46 et la Cx50. Nous avons aussi établi que la Cx46 et la Cx50 sont localisées dans différentes structures sous-cellulaires, ce qui suggère des rôles différents dans les cellules FS pour ces protéines de jonction lacunaire/communicante. Il est possible que la Cx46 et la Cx50 ne jouent pas un rôle majeur dans la communication intercellulaire dans les cellules FS quiescentes. Nos résultats suggèrent que la Cx46 et la Cx50 peuvent avoir d'autres fonctions : des isoformes de la Cx46 peuvent contribuer à la biogenèse des ribosomes tandis que la Cx50 pourrait avoir un rôle dans la communication dans les cellules stimulées au bFGF. Nos études établissent une base pour des recherches futures. / The folliculo-stellate (FS) cells of the anterior pituitary are star-shaped and extend long cytoplasmic processes forming pseudo-follicles encircling hormone-secreting cells. Dispersed throughout the anterior pituitary gland, FS cells are joined to form a continuous three dimensional network through communicating gap junctions. One of the primary roles of FS cells is the maintenance of the anterior pituitary microenvironment, accomplished through the expression and secretion of various growth factors and cytokines. These chemical messengers, including bFGF, VEGF, IL-6 and IL-1 mediate a range of cellular processes such as hormone gene expression. Our aim is to study whether intercellular communication among FS cells contributes to the modulatory activity of the FS cells within the anterior pituitary gland. To pursue this, we use the TtT/GF cell line that shares many morphological, physiological and biochemical characteristics with FS cells.
Gap junctions are formed by the joining of two connexons/hemichanels from adjacent cells that link their cytoplasms allowing for the passive diffusion of small molecules. Connexons/hemichannels are themselves formed by the oligomerization of six connexin (Cx) proteins from the family α, β or γ, which then migrate into the lipid bilayer of the cell membrane.
FS cells express Cx43 (α-connexin), which is regulated in response to growth factors and cytokines. Changes in the anterior pituitary microenvironment due to signaling molecules results in modifications to Cx43, particularly in the phosphorylation status of the protein. Such alterations yield alterations in the physiological behaviour of Cx43 gap junctions such as permeability and turnover.
Tissues generally express more than one connexin type and to date, Cx43 has been the sole connexin to be identified in FS cells. The ocular lens expresses the α-connexins: Cx43, Cx46 and Cx50, which are modulated by growth factors that are also present in the anterior pituitary. Based on these facts, we hypothesize that Cx46 and Cx50 are also expressed by the FS cells and contribute to the FS modulatory role in the anterior pituitary gland.
In the present study, we have identified and characterized Cx46 and Cx50 in the TtT/GF cell line. We identified Cx46 and Cx50 transcripts through northern blots and identified the corresponding protein products using antibodies and western blot analyses. Through confocal microscopy, we determined that Cx46 co-localized with the organelle markers: trans-Golgi, early endosomes and lysosomes. Cx50 co-localized with markers for the ER, cis-Golgi and early endosomes. An isolation procedure using a non-ionic detergent we showed that neither Cx46 nor Cx50 were associated to lipid rafts or caveolae. However, confocal microscopy showed a cytoplasmic co-localization between Cx50 and flotillin-1.
We pursued a finding that localized Cx46 to the nucleus and using a nuclear isolation technique, demonstrated that several isoforms of Cx46 are exclusively located in the nuclear compartment. Furthermore, with confocal microscopy we found a co-localization of Cx46 with a nucleolus/coiled body marker.
We demonstrated an effect of bFGF on the temporal expression patterns of Cx46 and Cx50 and showed that Cx46 levels decreased over longer exposures to the growth factor while Cx50 levels transiently increased. Lastly, drastic changes were noted in an in situ study of Cx46 and Cx50 in the male and female mink anterior pituitary during the annual reproductive cycle.
Our study indicates that addition to Cx43, FS cells also express Cx46 and Cx50. We also demonstrated that Cx46 and Cx50 localize to different sub-cellular structures, suggesting different roles in the FS cells. While they may not play a major role in intercellular communication in quiescent FS cells, our results suggest that Cx46 and Cx50 may serve other functions: Cx46 isoforms may contribute to ribosome biogenesis and Cx50 may have communication-related responsibilities in stimulated cells. Importantly, our identification and characterization studies provide a foundation on which future studies can be built.
|
Page generated in 0.018 seconds